Perbedaan Archi Indonesia Tbk dan UBC Medical Indonesia Tbk.: Archi Indonesia Tbk diperdagangkan di Rp1.200 (kapitalisasi pasar 31,42 T, volume 24 jam 23,62 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: Archi Indonesia Tbk jauh lebih besar — sekitar 49,4× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Archi Indonesia Tbk lebih aktif diperdagangkan (23,62 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ARCI | LABS | |
|---|---|---|
Kapitalisasi Pasar | 31,42 T | 635,95 M |
Volume | 23,62 jt | 843 rb |
Lot | 236,16 rb | 8,43 rb |
Perputaran | 28,62 M | 137,6 jt |
Harga Rata-rata | 1.211,87 | 163,22 |
Nilai Transaksi | 28,62 M | 137,6 jt |
Harga Ekuilibrium Indikatif | 1.200 | 165 |
Volume Ekuilibrium Indikatif | 6,49 rb | 246 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Selengkapnya di halaman ARCI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →